Cargando…

Dysregulation of Endothelin-1: Implications for Health Disparities in Alzheimer’s Disease

Alzheimer’s disease (AD) and related dementias disproportionately impact racial and ethnic minorities. The racial and ethnic disparities in AD could be explained by differences in cerebral vascular disease pathology. Endothelin-1 (ET-1) is a potent vasoconstrictive peptide that regulates smooth musc...

Descripción completa

Detalles Bibliográficos
Autor principal:	Alcendor, Donald J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712547/ https://www.ncbi.nlm.nih.gov/pubmed/33126567 http://dx.doi.org/10.3390/jpm10040199

Ejemplares similares

Evaluation of Health Disparity in Bacterial Vaginosis and the Implications for HIV‐1 Acquisition in African American Women
por: Alcendor, Donald J.
Publicado: (2016)

Interactions between Amyloid-Β Proteins and Human Brain Pericytes: Implications for the Pathobiology of Alzheimer’s Disease
por: J. Alcendor, Donald
Publicado: (2020)

Genetic dysregulation of endothelin-1 is implicated in coronary microvascular dysfunction
por: Ford, Thomas J, et al.
Publicado: (2020)

Zika virus infection and implications for kidney disease
por: Alcendor, Donald J.
Publicado: (2018)

Racial Disparities-Associated COVID-19 Mortality among Minority Populations in the US
por: Alcendor, Donald J.
Publicado: (2020)

Endothelin-1 in Health and Disease
por: Banecki, Katherine M. R. M., et al.
Publicado: (2023)

Intracellular Calcium Dysregulation: Implications for Alzheimer's Disease
por: Magi, Simona, et al.
Publicado: (2016)

BK Polyomavirus Virus Glomerular Tropism: Implications for Virus Reactivation from Latency and Amplification during Immunosuppression
por: Alcendor, Donald J.
Publicado: (2019)

Targeting COVID Vaccine Hesitancy in Rural Communities in Tennessee: Implications for Extending the COVID-19 Pandemic in the South
por: Alcendor, Donald J.
Publicado: (2021)

The Role of the Endothelin System in the Vascular Dysregulation Involved in Retinitis Pigmentosa
por: Sorrentino, Francesco Saverio, et al.
Publicado: (2015)

Endothelin and Endothelin Antagonists in Chronic Kidney Disease
por: Kohan, Donald E., et al.
Publicado: (2014)

Data on the involvement of endothelin-1 (ET-1) in the dysregulation of retinal veins
por: Kida, Teruyo, et al.
Publicado: (2018)

Targeting Endothelin in Alzheimer's Disease: A Promising Therapeutic Approach
por: Sharma, Shiwali, et al.
Publicado: (2021)

Endothelin
por: Davenport, Anthony P., et al.
Publicado: (2016)

Targeting COVID-19 Vaccine Hesitancy in Minority Populations in the US: Implications for Herd Immunity
por: Hildreth, James E. K., et al.
Publicado: (2021)

Role of endothelin-1 in lung disease
por: Fagan, Karen A, et al.
Publicado: (2001)

Calpain Dysregulation in Alzheimer's Disease
por: Ferreira, Adriana
Publicado: (2012)

Zika virus infection of cellular components of the blood-retinal barriers: implications for viral associated congenital ocular disease
por: Roach, Tracoyia, et al.
Publicado: (2017)

Dysregulation of the endothelin pathway in lymphangioleiomyomatosis with no direct effect on cell proliferation and migration
por: Chebib, Nader, et al.
Publicado: (2018)

Dysregulation of Astrocyte–Neuronal Communication in Alzheimer’s Disease
por: Nanclares, Carmen, et al.
Publicado: (2021)

Iron Dysregulation in Mitochondrial Dysfunction and Alzheimer’s Disease
por: Onukwufor, John O., et al.
Publicado: (2022)

The Role of Endothelin-1 and Endothelin Receptor Antagonists in Inflammatory Response and Sepsis
por: Kowalczyk, Agata, et al.
Publicado: (2014)

Therapeutic Strategies to Target Calcium Dysregulation in Alzheimer’s Disease
por: Calvo-Rodriguez, Maria, et al.
Publicado: (2020)

Human Vascular Pericytes and Cytomegalovirus Pathobiology
por: Alcendor, Donald J.
Publicado: (2019)

Resveratrol, Metabolic Dysregulation, and Alzheimer’s Disease: Considerations for Neurogenerative Disease
por: Yang, Alex J. T., et al.
Publicado: (2021)

Endothelin Receptor Antagonists in Kidney Disease
por: Martínez-Díaz, Irene, et al.
Publicado: (2023)

Emerging insights into synapse dysregulation in Alzheimer’s disease
por: Martínez-Serra, Raquel, et al.
Publicado: (2022)

Endothelin Blockade in Diabetic Kidney Disease
por: Anguiano, Lidia, et al.
Publicado: (2015)

“The possible implication of endothelin in the pathology of COVID-19-induced pulmonary hypertension”
por: Nabeh, Omnia Azmy, et al.
Publicado: (2021)

Dysregulated Wnt Signalling in the Alzheimer’s Brain
por: Aghaizu, Nozie D., et al.
Publicado: (2020)

The primary vascular dysregulation syndrome: implications for eye diseases
por: Flammer, Josef, et al.
Publicado: (2013)

Decreased Endothelin-1 Plasma Levels in Multiple Sclerosis Patients: A Possible Factor of Vascular Dysregulation?
por: Jankowska-Lech, Irmina, et al.
Publicado: (2015)

Could autophagy dysregulation link neurotropic viruses to Alzheimer’s disease?
por: Romeo, Maria Anele, et al.
Publicado: (2019)

Endothelin and endothelial dysfunction
por: Masaki, Tomoh, et al.
Publicado: (2006)

Retinal pericytes and cytomegalovirus infectivity: implications for HCMV-induced retinopathy and congenital ocular disease
por: Wilkerson, Irene, et al.
Publicado: (2015)

Vivo-Morpholino-Based Antiviral for SARS-CoV-2: Implications for Novel Therapies in the Treatment of Acute COVID-19 Disease
por: Hildreth, James E. K., et al.
Publicado: (2021)

The importance of endothelin-1 for microvascular dysfunction in diabetes
por: Kalani, Majid
Publicado: (2008)

Vaccine Confidence and Uptake of the Omicron Bivalent Booster in Tennessee: Implications for Vulnerable Populations
por: Alcendor, Donald J., et al.
Publicado: (2023)

Implications of Tau Dysregulation in Huntington’s Disease and Potential for New Therapeutics
por: Mees, Isaline, et al.
Publicado: (2023)

Intracellular Calcium Dysregulation by the Alzheimer’s Disease-Linked Protein Presenilin 2
por: Galla, Luisa, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_p7169fjego81rhnmebevj8a0l5